CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Growth in the Lipid Nanoparticles (LNPs) market is driven by increasing demand for mRNA-based therapeutics and advances in ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

Russia becomes the first country to deploy a cancer vaccine, launching trials within months. Using cutting-edge mRNA technology, the treatment is personalised to target a patient’s tumour. With ...

The company posted strong second-quarter results and reaffirmed its guidance for 2025. Enbridge posted EBITDA of C$4.6 ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The Mpox outbreak has renewed interest in Kenya from various foreign vaccine suppliers. One of the few WHO-approved Mpox ...

The most special thing about a vaccine is that it not only controls or reduces the disease, but taking it does not cause the ...

BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...

Professor Watson is excited to announce the launch of an online summer course called “Ethics in the Workplace,” taught by Dr.

Notably, Pfizer’s Comirnaty Covid vaccine is still approved or authorized for people 6 months of age and older without any restrictions based on risk factors for Covid — at least for now. But the FDA ...